Business Standard

Kimia Biosciences Share Price

Know More
NSEBSE
Stock not traded

52.380.55 (1.06%)

04:01 PM,18th Apr 2024

BSE : 530313

NSE :

Sector : Health care

ISIN Code : INE285U01025

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 18 2024 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

1

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Kimia Biosciences Ltd

Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September 1993 led by the Promoters A K Bansal K S Varma Atul Sharma A P Godiyal D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon Haryana. The Company is engaged into the business of Pharamaceutical products.The company set up a bulk drug manufacturing unit at Gurgaon Haryana at a project cost of Rs 10.41 cr. It came out with a public issue in Feb.'95 to part-finance the project. Commercial production commenced in May '95. During the 1998-99 the company has become a sick industrial units.The Hon'ble BIFR vide order dated 27th December 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and thereby turning-out to be an ancillary industrial Undertaking. .The Hon'ble AAIFR disposed the appeal of M/s Ranbaxy Lab. Ltd vide its Order dated 30.08.2006 directing them to file an application before the Ho'ble BIFR only to redress grievances. Therefore M/s Ranbaxy Lab. Ltd had filed an application-dated 31.10.06 before the Hon'ble BIFR requesting them to consider issuance of appropriate corrective orders. The Board has re-confirmed its earlier order. Therefore despite negative net worth the Company is out of BIFR purview.During the year 2017-18 the Scheme of Arrangement for Amalgamation of the Company with M/s Kimia Biosciences Limited was made effective from September 17 2018. Upon Scheme of Amalgamation becoming effective on 17.09.2018 M/s. Kimia Biosciences Limited Holding Company having 3728100 Equity Shares (50.48%) of Rs. 10/- each of the Company got merged under reverse merger with the Company.

Kimia Biosciences Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

247

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

654.75

Face Value (₹) 1
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]0.08
P/B Ratio (₹) [S]654.75
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

51.18

54.00

Week Low/High

50.92

55.00

Month Low/High

50.50

58.00

Year Low/High

31.99

58.00

All time Low/High

0.60

77.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.22%%-3.40-3.33%
1 Month1.61%%-0.36-0.27%
3 Month39.64%%1.832.49%
6 Month44.86%%10.0411.82%
1 Year44.74%%21.3724.55%
3 Year21.96%%48.4550.47%

Company Info

Company Information

Chairman & Managing Director : Sameer Goel

Independent Director : Jagdeep Dhavvan

Independent Director : Richa Gupta

Director : Vipul Goel

Company Sec. & Compli. Officer : Lakshay Prakash

Registered Office: Bhondsi Village, Tehsil Sohna,Gurgaon,Haryana-122102 Ph: 91-11-29535650

Email:compliance.kimia@gmail.com

URL:http://www.kimiabiosciences.com